RUNX1 was also up-regulated in CN-AML patients, as well as gene sets that regulate the cellular cycle and proliferation, particularly c-kit, FLT3, MYCN, MYB, MYC, and CDK6, RUNX1high were associated with poorer OS and EFS of CN-AML patients (118). This evidence concerns the gene MYCN and acute myeloid leukemia.